CARDIOPULMONARY EXERCISE TESTING WITH SUPRAMAXIMAL VERIFICATION PRODUCES A SAFE AND VALID ASSESSMENT OF V̇O2max IN PEOPLE WITH CYSTIC FIBROSIS

Adam J. Causer,Janis K. Shute,Michael H. Cummings,Anthony I. Shepherd,Victoria Bright,Gary Connett,Mark I. Allenby,Mary P. Carroll,Thomas W.V. Daniels,Zoe L. Saynor

CARDIOPULMONARY EXERCISE TESTING WITH SUPRAMAXIMAL VERIFICATION PRODUCES A SAFE AND VALID ASSESSMENT OF V̇O2max IN PEOPLE WITH CYSTIC FIBROSIS

2018

Adam J. Causer
Janis K. Shute
Michael H. Cummings
Anthony I. Shepherd
Victoria Bright
Gary Connett
Mark I. Allenby
Mary P. Carroll
Thomas W.V. Daniels
Zoe L. Saynor

Incorporating supramaximal verification into cardiopulmonary exercise testing protocols did not increase the frequency of adverse events or perceived discomfort versus a single-phase incremental ex...

Keywords:

Diabetes mellitus
Cystic fibrosis
Anesthesia
Respiratory disease
Testing protocols
Cardiorespiratory fitness
VO2 max
Adverse effect
Chemistry
cardiopulmonary exercise testing
retrospective analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations